Exelixis EXEL
$64.63 −$1.20 (-1.82%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $64.63 0.00%
Open$65.95
Prev close$65.83
Day range$64.45 – $66.94
Volume2.19M
Market cap$15.77B
P/E (TTM)19.4
Dividend yield–
EXEL Stock News
Headlines matching Exelixis or the EXEL ticker, most recent first.
- Truist Financial Maintains Exelixis(EXEL.US) With Hold Rating
- Analysts Offer Insights on NA Companies: Exelixis (EXEL) and Resolution Minerals Ltd. Sponsored ADR (RML)
- BofA Securities Maintains Exelixis(EXEL.US) With Sell Rating, Maintains Target Price $41
- Stifel Maintains Exelixis(EXEL.US) With Hold Rating
- William Blair Maintains Exelixis(EXEL.US) With Buy Rating
- Goldman Sachs Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $64
- Truist Financial Maintains Exelixis(EXEL.US) With Hold Rating, Raises Target Price to $56 Positive
- Goldman Sachs Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $64 Positive
- Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (CAI) and Exelixis (EXEL)
- H.C. Wainwright Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $56
- Truist Financial Downgrades Exelixis(EXEL.US) to Hold Rating, Raises Target Price to $54 Mixed
- Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Kiora Pharmaceuticals (KPRX) and MAIA Biotechnology, Inc. (MAIA)
- Stifel Maintains Exelixis(EXEL.US) With Hold Rating, Announces Target Price $47
- H.C. Wainwright Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $56 Positive
- A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $45 to $55
No comments yet — be the first to weigh in on EXEL.
Sign in to join the discussion.